Show 2 records for TSPARMCD = "GLPTYP", using TSSEQ to indicate multiple records,Image ModifiedTOBA-366UNDER GGG REVIEWsince both GLP types apply for this study.
Row 3:
Shows that this study was conducted as a GLP study.
Rows 4-5:
Shows the study start date and study title.
Rows 6-7:
Show the version of SEND Implementation Guide and version of Controlled Terminology used in this study.
Row 8:
Shows the applicant's organization.
Row 9:
Shows that the applicant's study reference ID is not applicable.
Rows 10-13:
Show that TSGRPID has been used to link records (name, location, country) related to the test facility (TSGRPID=1). The study director is associated with the test facility.
Rows 14-16:
Show that TSGRPID (TSGRPID=4) has been used to link the information on the testing guideline followed on this study (TSTGDNAM, TSTGDORG, TSTGDVER). Image ModifiedTOBA-56-Assay StandardDONE
Row 17:
Shows the study type for this study.
Row 18:
Shows that this study includes a Mammalian Cell Micronucleus Assay.
Rows 19-27:
Show that TSGRPID (TSGRPID = 2) has been used to link the information for 1 species (salmonella) with the 4 different strains and cell lines that are tested in this study.
Rows 28-30:
Show that TSGRPID (TSGRPID = 3) has been used to link the information for 1 species (E. coli) with the strain and cell line that is tested in this study.Image ModifiedTOBA-665UNDER G
Rowcaps
Rows 1-2:
Show 2 records for TSPARMCD = "GLPTYP", using TSSEQ to indicate multiple records, since both GLP types apply for this example study.
Row 3:
Shows that this study was conducted as a GLP study.
Rows 4-5:
Shows Show the study start date and study title.
Rows 6-7:
Show the version of SEND Implementation Guide and version of Controlled Terminology used in this study.
Row 8:
Shows the applicant's organization.
Row 9:
Shows that the applicant's study reference ID is not applicable.
Rows 10-13:
Show that TSGRPID has been used to link records (name, location, country) related to the test facility (TSGRPID = 1). The study director is associated with the test facility.
Rows 14-16:
Show that TSGRPID (TSGRPID=2) has been used to link the information on the testing guideline followed on this study (TSTGDNAM, TSTGDORG, TSTGDVER).
Jira
showSummary
false
server
Issue Tracker (JIRA)
serverId
85506ce4-3cb3-3d91-85ee-f633aaaf4a45
key
TOBA-56
Row 17:
Shows the study type for this study.
Row 18:
Shows that this study includes a Mammalian Cell Micronucleus Assay.
Rows 19-20:
Show that the species is human and the cell line is TK6 lymphoblastoid in this study.
Dataset2
Row
STUDYID
DOMAIN
TSSEQ
TSGRPID
TSPARMCD
TSPARM
TSVAL
TSVALNF
1
123
TS
1
GLPTYP
Good Laboratory Practice Type
FDA
2
123
TS
2
GLPTYP
Good Laboratory Practice Type
OECD
3
123
TS
1
GLPFL
GLP Flag
Y
4
123
TS
1
STSTDTC
Study Start Date
2022-05-25
5
123
TS
1
STITLE
Study Title
Determination of the in vitro genotoxicity potential using the in vitro Neutral Red Uptake assay